Among patients with gout in the US, Black individuals and those living in the South were associated with reduced adherence to allopurinol.

The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. | Following some ...

Takeda has ended the manufacturing and supply of its gout drug Uloric in the US market as more patients turn to generic ...

Rheumatologists report largely adhering to American College of Rheumatology guidelines for gout management, but show notable ...